@article{f5d3d1c6444c4a10a418d9b9c9070ebe,
title = "Germline BRCA1/2 (gBRCA1/2) Testing Patterns among Oncologists (ONC) Treating HER2- advanced Breast Cancer (ABC): Results from a Multi-country Real-world Study",
abstract = " Niyazov; K. Lewis; R. Wild; A. Rider; B. Arondekar; M.P. Lux ",
author = "Reshma Mahtani",
note = "Recently, poly ADP-ribose polymerases inhibitors (PARPi) in HER2- ABC have become available and international guidelines have broadened the eligibility criteria for gBRCA1/2 testing. We assessed gBRCA1/2 testing patterns among ONC treating HER2- ABC in the US, Israel and France, Germany, Italy and Spain (EU4).",
year = "2020",
language = "American English",
volume = "31",
journal = "Annals of Oncology / European Society for Medical Oncology (ESMO) Breast Conference",
}